๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Neuroendocrine Carcinoma of the Bladder

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies NCT04923178n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) Sample Collection for Ongoing Research and Product Evaluation Study NCT07318051n/a1 site๐Ÿ“ Austin Natera, Inc. Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma NCT06091124Phase 25 sites๐Ÿ“ Nanjing๐Ÿ“ Xi'an๐Ÿ“ Shanghai RenJi Hospital ยท Tests: Adebrelimab, Etoposide, Cisplatin, Radical Cystectomy Evaluation for NCI Surgery Branch Clinical Research Protocols NCT00001823n/a1 site๐Ÿ“ Bethesda National Cancer Institute (NCI) EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ยฑ Pembrolizumab in Advanced Solid Tumors NCT07410676Phase 1, Phase 21 site๐Ÿ“ Beijing Essen Biotech ยท Tests: EBNK-001 + IL-15 + Pembrolizumab Quantifying Systemic Immunosuppression to Personalize Cancer Therapy NCT05621837n/a1 site๐Ÿ“ Milan Fondazione IRCCS Istituto Nazionale dei Tumori, Milano ยท Tests: MDSC quantification Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE) NCT04498767NA13 sites๐Ÿ“ Anderlecht๐Ÿ“ Ghent๐Ÿ“ Wilrijk European Organisation for Research and Treatment of Cancer โ€ฆ ยท Tests: Stereotactic body radiotherapy, Palliative RT Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... NCT06161532Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Sacituzumab govitecan, Atezolizumab Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease NCT06529822Phase 13 sites๐Ÿ“ Orlando๐Ÿ“ St Louis๐Ÿ“ Columbus Washington University School of Medicine ยท Tests: Synthetic long peptide personalized cancer vaccine, Poly ICLC, Signatera or Altera testing INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) NCT07403630NA2 sites๐Ÿ“ Palermo๐Ÿ“ Perugia Azienda Ospedaliero-Universitaria di Parma ยท Tests: Functional tests, Multi-omics analyses, Cytogenetics/ FISH Integrated Cancer Repository for Cancer Research NCT02012699n/a42 sites๐Ÿ“ Greenwood Village๐Ÿ“ Manchester๐Ÿ“ Daytona Beach University of Nebraska Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors NCT03866382Phase 2582 sites๐Ÿ“ Birmingham๐Ÿ“ Anchorage๐Ÿ“ Anchorage National Cancer Institute (NCI) ยท Tests: Biospecimen Collection, Bone Scan, Cabozantinib S-malate, Computed Tomography, Echocardiography Test A Study of MGC026 in Participants With Advanced Solid Tumors NCT06242470Phase 112 sites๐Ÿ“ Los Angeles๐Ÿ“ Grand Rapids๐Ÿ“ Lake Success MacroGenics ยท Tests: MGC026 Dose Escalation, MGC026 Dose for Expansion, Pembrollizumab, vobramitamab tavatecan A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue NCT05837767NA7 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Palliative radiotherapy Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors NCT07278479Phase 1, Phase 28 sites๐Ÿ“ Tampa๐Ÿ“ Atlanta๐Ÿ“ Chicago Molecular Partners AG ยท Tests: [212Pb]Pb-MP0712, [203Pb]Pb-MP0712 At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer NCT05969860Phase 22 sites๐Ÿ“ Jacksonville๐Ÿ“ Grand Forks Mayo Clinic ยท Tests: Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment, Questionnaire Administration A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas. NCT06022029Phase 116 sites๐Ÿ“ Los Angeles๐Ÿ“ Tamarac๐Ÿ“ Canton OncoNano Medicine, Inc. ยท Tests: ONM-501, Cemiplimab Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer NCT05312671Phase 22 sites๐Ÿ“ Washington D.C.๐Ÿ“ Baltimore Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Atezolizumab, Carboplatin, Cisplatin, Etoposide, Cystectomy Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05) NCT07327489n/a8 sites๐Ÿ“ Fort Smith๐Ÿ“ Frederick๐Ÿ“ Springfield Elephas ยท Tests: Biopsy SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774n/a68 sites๐Ÿ“ Birmingham๐Ÿ“ Mobile๐Ÿ“ Scottsdale Massive Bio, Inc. ยท Tests: Clinical Trial Matching A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626Phase 1, Phase 219 sites๐Ÿ“ Sacramento๐Ÿ“ Celebration๐Ÿ“ Miami Marengo Therapeutics, Inc. ยท Tests: STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection NCT06503146Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: [18F]FAPI-74, [18F]FDG Predictive Value of Progastrin Titer at Diagnosis and of Progastrin Kinetics During Treatment in Cancer Patients NCT03787056NA17 sites๐Ÿ“ Bron๐Ÿ“ Lyon๐Ÿ“ Lyon Hospices Civils de Lyon ยท Tests: Blood draws Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial NCT06580002Phase 21 site๐Ÿ“ Orange University of California, Irvine ยท Tests: Riluzole, Placebo Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors NCT06814496Phase 1, Phase 23 sites๐Ÿ“ Gilbert๐Ÿ“ Tucson๐Ÿ“ Seattle University of Arizona ยท Tests: Tarlatamab, Concurrent Radiation Therapy, Sequential Radiation therapy Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types NCT05000294Phase 1, Phase 21 site๐Ÿ“ Gainesville University of Florida ยท Tests: Atezolizumab, Tivozanib Cancer Experience Registry (CER) for Cancer Patients and Caregivers NCT02333604n/a1 site๐Ÿ“ Washington D.C. Cancer Support Community, Research and Training Institute, โ€ฆ A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors NCT06172478Phase 296 sites๐Ÿ“ Duarte๐Ÿ“ New Haven๐Ÿ“ Kissimmee Daiichi Sankyo ยท Tests: HER3-DXd The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas NCT07285044Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Cancer Therapeutic Procedure, Cancer Therapeutic Procedure, Questionnaire Administration
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy